- Home
- CLLS vs CIO Comparison
CLLS vs CIO Comparison
Compare CLLS & CIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLLS
- CIO
- Stock Information
- Founded
- CLLS 1999
- CIO 2013
- Country
- CLLS France
- CIO Canada
- Employees
- CLLS N/A
- CIO N/A
- Industry
- CLLS Biotechnology: Pharmaceutical Preparations
- CIO Real Estate Investment Trusts
- Sector
- CLLS Health Care
- CIO Real Estate
- Exchange
- CLLS Nasdaq
- CIO Nasdaq
- Market Cap
- CLLS 299.0M
- CIO 280.5M
- IPO Year
- CLLS 2007
- CIO 2014
- Fundamental
- Price
- CLLS $3.49
- CIO $6.93
- Analyst Decision
- CLLS Buy
- CIO Hold
- Analyst Count
- CLLS 1
- CIO 1
- Target Price
- CLLS $8.00
- CIO N/A
- AVG Volume (30 Days)
- CLLS 212.5K
- CIO 415.8K
- Earning Date
- CLLS 11-03-2025
- CIO 11-06-2025
- Dividend Yield
- CLLS N/A
- CIO 5.77%
- EPS Growth
- CLLS N/A
- CIO N/A
- EPS
- CLLS N/A
- CIO N/A
- Revenue
- CLLS $63,438,000.00
- CIO $168,892,000.00
- Revenue This Year
- CLLS N/A
- CIO $0.60
- Revenue Next Year
- CLLS $66.76
- CIO $3.53
- P/E Ratio
- CLLS N/A
- CIO N/A
- Revenue Growth
- CLLS 223.09
- CIO N/A
- 52 Week Low
- CLLS $1.10
- CIO $4.19
- 52 Week High
- CLLS $5.48
- CIO $7.01
- Technical
- Relative Strength Index (RSI)
- CLLS 47.81
- CIO 45.25
- Support Level
- CLLS $3.39
- CIO $6.92
- Resistance Level
- CLLS $5.48
- CIO $7.00
- Average True Range (ATR)
- CLLS 0.38
- CIO 0.02
- MACD
- CLLS -0.10
- CIO -0.01
- Stochastic Oscillator
- CLLS 6.38
- CIO 12.50
About CLLS Cellectis S.A.
Cellectis SA is a clinical stage biotechnological company, employing the core proprietary technologies to develop products based on gene-editing, with a portfolio of allogeneic Chimeric Antigen Receptor T-cells, or UCART, product candidates in the field of immuno-oncology and gene-edited hematopoietic stem and progenitor cells, or HSPC product candidates in other therapeutic indications.
About CIO City Office REIT Inc.
City Office REIT Inc is a real estate investment trust. It is focused on acquiring, owning, and operating high-quality office properties located predominantly in Sun Belt markets. The principal objective of the company is to provide attractive risk-adjusted returns to its investors over the long-term through a combination of dividends and capital appreciation. Its properties includes: Pima Center, SanTan, Park Tower, Intellicenter, Intellicenter, Denver Tech, Canyon Park, AmberGlen and many. The company own these office buildings in the metropolitan areas of Dallas, Denver, Orlando, Phoenix, Portland, Raleigh, San Diego, Seattle, and Tampa.